3d gre sequence with magnetization-preparation 3d tfe (Philips Healthcare)
90
Structured Review
Philips Healthcare
3d gre sequence with magnetization-preparation 3d tfe
3d Gre Sequence With Magnetization Preparation 3d Tfe, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/3d+gre+sequence+with+magnetization-preparation+3d+tfe/3d+gre+sequence+with+magnetization+preparation+3d+tfe/pm37658891-78-3-12
Average 90 stars, based on 1 article reviews
3d Gre Sequence With Magnetization Preparation 3d Tfe, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/3d+gre+sequence+with+magnetization-preparation+3d+tfe/3d+gre+sequence+with+magnetization+preparation+3d+tfe/pm37658891-78-3-12
Average 90 stars, based on 1 article reviews
3d gre sequence with magnetization-preparation 3d tfe - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Magnetic Resonance Imaging:Article Title: Use of gadolinium-based contrast agents in multiple sclerosis: a review by the ESMRMB-GREC and ESNR Multiple Sclerosis Working Group. Article Snippet: Magnetic resonance imaging (MRI) is the most sensitive technique for detecting inflammatory demyelinating lesions in multiple sclerosis (MS) and plays a crucial role in diagnosis and monitoring treatment effectiveness, and for predicting the disease course.. In clinical practice, detection of MS lesions is mainly based on T2-weighted and contrast-enhanced T1-weighted sequences.. Contrast-enhancing lesions (CEL) on T1-weighted sequences are related to (sub)acute inflammation, while new or enlarging T2 lesions reflect the permanent footprint from a previous acute inflammatory demyelinating event. Sequencing:Article Title: Use of gadolinium-based contrast agents in multiple sclerosis: a review by the ESMRMB-GREC and ESNR Multiple Sclerosis Working Group. Article Snippet: Magnetic resonance imaging (MRI) is the most sensitive technique for detecting inflammatory demyelinating lesions in multiple sclerosis (MS) and plays a crucial role in diagnosis and monitoring treatment effectiveness, and for predicting the disease course.. In clinical practice, detection of MS lesions is mainly based on T2-weighted and contrast-enhanced T1-weighted sequences.. Contrast-enhancing lesions (CEL) on T1-weighted sequences are related to (sub)acute inflammation, while new or enlarging T2 lesions reflect the permanent footprint from a previous acute inflammatory demyelinating event. |